Sara Llamas-Velasco
Overview
Explore the profile of Sara Llamas-Velasco including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
28
Citations
216
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Contador I, Buch-Vicente B, Del Ser T, Llamas-Velasco S, Villarejo-Galende A, Benito-Leon J, et al.
J Clin Med
. 2024 Jul;
13(14).
PMID: 39064140
Alzheimer's disease (AD), the most common cause of dementia, is a complex and multifactorial condition without cure at present. The latest treatments, based on anti-amyloid monoclonal antibodies, have only a...
2.
Alcala Torres J, Llamas-Velasco S, Santos Martin C, Mendez Guerrero A
Int J Neurosci
. 2024 Jan;
:1-7.
PMID: 38294709
Purpose: To examine the link between tremor and sex chromosome abnormalities, emphasizing the necessity of comprehensive physical examination. Case Description: An 18-year-old man exhibited an isolated action tremor in both...
3.
Llamas-Velasco S, Ferreiro C, Gonzalez Fuertes A, Garcia Tell P, Blanco-Palmero V, Martin-Jimenez P, et al.
Disabil Rehabil
. 2023 Feb;
:1-5.
PMID: 36824018
Purpose: To assess the feasibility and effects on manual dexterity and the quality of life (QoL) of a 12-week home calligraphic training program in patients with Parkinson's disease (PD). Methods:...
4.
Gomez-Grande A, Seiffert A, Villarejo-Galende A, Gonzalez-Sanchez M, Llamas-Velasco S, Bueno H, et al.
Rev Esp Med Nucl Imagen Mol (Engl Ed)
. 2023 Feb;
42(4):211-217.
PMID: 36758828
Objective: To study the correlation between a static PET image of the first-minute-frame (FMF) acquired with F-labeled amyloid-binding radiotracers and brain [F]FDG PET in patients with primary progressive aphasia (PPA)....
5.
Hidalgo Mayoral I, Martinez-Salio A, Llamas-Velasco S, Gomez-Majon I, Arteche-Lopez A, Quesada-Espinosa J, et al.
Eur J Med Genet
. 2022 Jun;
65(8):104539.
PMID: 35705147
Cerebral autosomal recessive arteriopathy with subcortical infarcts and leukoencephalopathy (CARASIL) is an autosomal recessive vascular disorder caused by biallellic variants in HTRA1. Recently, it has been reported that several heterozygous...
6.
Contador I, Alzola P, Bermejo-Pareja F, Del Ser T, Llamas-Velasco S, Fernandez-Calvo B, et al.
J Alzheimers Dis
. 2022 May;
88(1):291-299.
PMID: 35570491
Background: A protective effect of education on cognitive decline after stroke has been claimed, but evidence from prospective population-based cohorts is very limited. The differential role of literacy and education...
7.
Alvarez-Mora M, Blanco-Palmero V, Quesada-Espinosa J, Arteche-Lopez A, Llamas-Velasco S, Palma Milla C, et al.
Int J Mol Sci
. 2022 Apr;
23(8).
PMID: 35457051
In the last few years, the SORL1 gene has been strongly implicated in the development of Alzheimer’s disease (AD). We performed whole-exome sequencing on 37 patients with early-onset dementia or...
8.
Bermejo-Pareja F, Gomez de la Camara A, Del Ser T, Contador I, Llamas-Velasco S, Lopez-Arrieta J, et al.
Aging Clin Exp Res
. 2022 Jan;
34(6):1275-1283.
PMID: 35025095
Background: The causes of the dementia decrease in affluent countries are not well known but health amelioration could probably play a major role. Nevertheless, although many vascular and systemic disorders...
9.
Touchscreen Smartphone Interaction in Parkinson's Disease and Healthy Subjects in Outpatient Clinics
Lopez-Blanco R, Llamas-Velasco S, Velasco M
Mov Disord Clin Pract
. 2021 Nov;
8(8):1278-1280.
PMID: 34765695
No abstract available.
10.
Gonzalez-Ortega G, Llamas-Velasco S, Arteche-Lopez A, Quesada-Espinosa J, Puertas-Martin V, Gomez-Grande A, et al.
J Alzheimers Dis
. 2021 Aug;
84(1):73-78.
PMID: 34459404
The haploinsufficiency of the methyl-binding domain protein 5 (MBD5) gene has been identified as the determinant cause of the neuropsychiatric disorders grouped under the name MBD5-neurodevelopment disorders (MAND). MAND includes...